BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rong MH, Li JD, Zhong LY, Huang YZ, Chen J, Xie LY, Qin RX, He XL, Zhu ZH, Huang SN, Zhou XG. CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle. Exp Biol Med (Maywood) 2021;:15353702211049149. [PMID: 34743578 DOI: 10.1177/15353702211049149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Song G, He T, Ji K, Duan Y, Zhang J, Hu G. SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1038925] [Reference Citation Analysis]
2 Li D, Li K, Zhang W, Yang K, Mu D, Jiang G, Shi R, Ke D. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma. Front Immunol 2022;13:918140. [DOI: 10.3389/fimmu.2022.918140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]